Cargando…

Editorial: Decreasing the Impact of Treatment Resistance in Schizophrenia: Identifying Novel Molecular Targets/Pathways to Increase Treatment Efficacy

Detalles Bibliográficos
Autores principales:	Manchia, Mirko, Carpiniello, Bernardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346737/ https://www.ncbi.nlm.nih.gov/pubmed/32714191 http://dx.doi.org/10.3389/fphar.2020.01001

Ejemplares similares

The Impact of Alexithymia on Treatment Response in Psychiatric Disorders: A Systematic Review
por: Pinna, Federica, et al.
Publicado: (2020)

Clinicians’ adherence to clinical practice guidelines for cardiac function monitoring during antipsychotic treatment: a retrospective report on 434 patients with severe mental illness
por: Manchia, Mirko, et al.
Publicado: (2017)

Involvement of Gut Microbiota in Schizophrenia and Treatment Resistance to Antipsychotics
por: Manchia, Mirko, et al.
Publicado: (2021)

Leukocytosis Associated with Clozapine Treatment: A Case Series and Systematic Review of the Literature
por: Paribello, Pasquale, et al.
Publicado: (2021)

Peripheral Biomarkers in Schizophrenia: A Meta-Analysis of Microarray Gene Expression Datasets
por: Piras, Ignazio S, et al.
Publicado: (2018)

Challenges and Future Prospects of Precision Medicine in Psychiatry
por: Manchia, Mirko, et al.
Publicado: (2020)

Critical appraisal of 3-monthly paliperidone depot injections in the treatment of schizophrenia
por: Carpiniello, Bernardo, et al.
Publicado: (2016)

Treatment-Resistant Schizophrenia: Genetic and Neuroimaging Correlates
por: Vita, Antonio, et al.
Publicado: (2019)

Predominant Polarity and Polarity Index of Maintenance Treatments for Bipolar Disorder: A Validation Study in a Large Naturalistic Sample in Italy
por: Albert, Umberto, et al.
Publicado: (2021)

Glycine Signaling in the Framework of Dopamine-Glutamate Interaction and Postsynaptic Density. Implications for Treatment-Resistant Schizophrenia
por: de Bartolomeis, Andrea, et al.
Publicado: (2020)

Melatonin and aggressive behavior: A systematic review of the literature on preclinical and clinical evidence
por: Paribello, Pasquale, et al.
Publicado: (2022)

Editorial: Late-onset depression and mania: Diagnosis, treatment and life events as risk factors
por: Janiri, Delfina, et al.
Publicado: (2022)

Editorial: Novel Approaches to the Treatment of Multidrug-Resistant Bacteria
por: Pusparajah, Priyia, et al.
Publicado: (2022)

Pharmacological Treatment of Bipolar Depression: A Review of Observational Studies
por: Fellendorf, Frederike T., et al.
Publicado: (2023)

Editorial: Inflammation and immune diseases: Molecular targets for pathogenesis and treatment
por: Wu, Fan-Rong
Publicado: (2023)

Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia
por: Crocker, Candice E., et al.
Publicado: (2018)

Peripheral biomarkers of treatment-resistant schizophrenia: Genetic, inflammation and stress perspectives
por: Jiao, Shimeng, et al.
Publicado: (2022)

Corrigendum: Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia
por: Crocker, Candice E., et al.
Publicado: (2018)

Treatment-Resistant Schizophrenia: Insights From Genetic Studies and Machine Learning Approaches
por: Pisanu, Claudia, et al.
Publicado: (2019)

Clozapine Metabolism is Associated With Absolute Neutrophil Count in Individuals With Treatment-Resistant Schizophrenia
por: Willcocks, Isabella R., et al.
Publicado: (2021)

The Role of Gut Microbiota in the High-Risk Construct of Severe Mental Disorders: A Mini Review
por: Sani, Gabriele, et al.
Publicado: (2021)

Editorial: Novel approaches to the treatment of multidrug-resistant bacteria, Volume II
por: Pusparajah, Priyia, et al.
Publicado: (2022)

Exploring the Role of Gut Microbiota in Major Depressive Disorder and in Treatment Resistance to Antidepressants
por: Fontana, Andrea, et al.
Publicado: (2020)

Treatment-refractory schizophrenia
por: Caspi, Asaf, et al.
Publicado: (2004)

Pharmacologic treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2010)

Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial
por: Shi, Hui, et al.
Publicado: (2022)

Editorial: Systematic reviews of pharmacological and non-pharmacological psychiatric interventions
por: Manchia, Mirko, et al.
Publicado: (2023)

Editorial: Cannabidiol Treatment in Neurotherapeutic Interventions
por: Gonzalez-Cuevas, Gustavo, et al.
Publicado: (2021)

Haplotypic and Genotypic Association of Catechol-O-Methyltransferase rs4680 and rs4818 Polymorphisms and Treatment Resistance in Schizophrenia
por: Sagud, Marina, et al.
Publicado: (2018)

Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and Agranulocytosis
por: Numata, Shusuke, et al.
Publicado: (2018)

Studies in schizophrenia: pathophysiology and treatment
por: Tamminga, Carol A., et al.
Publicado: (2002)

Editorial: Prevention, diagnosis and treatment of rare disorders
por: Cox, Timothy M., et al.
Publicado: (2022)

Editorial: Natural product treatment of gastrointestinal diseases
por: Sun, Mingyu, et al.
Publicado: (2022)

Editorial: Translating nanomedicines for anti-cancer treatment
por: Siram, Karthik, et al.
Publicado: (2023)

The Microbiome: A New Target for Research and Treatment of Schizophrenia and its Resistant Presentations? A Systematic Literature Search and Review
por: Cuomo, Alessandro, et al.
Publicado: (2018)

Effects of low-dose combined olanzapine and sertraline on negative and depressive symptoms in treatment-resistant outpatients with acute exacerbated schizophrenia
por: Lang, Xiaoe, et al.
Publicado: (2023)

Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment?
por: Beggiato, Sarah, et al.
Publicado: (2021)

Longitudinal assessment of brain-derived neurotrophic factor in Sardinian psychotic patients (LABSP): a protocol for a prospective observational study
por: Primavera, Diego, et al.
Publicado: (2017)

Investigations of nitazoxanide molecular targets and pathways for the treatment of hepatocellular carcinoma using network pharmacology and molecular docking
por: Khan, Shakeel Ahmad, et al.
Publicado: (2022)

Editorial: Novel Therapeutic Targets and Emerging Treatments for Fibrosis
por: Samuel, Chrishan S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_0vu9bul3p2l59knvj92svlg356